VIATRIS INC. for VIATRIS INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 20, 2012 | $490,457 | Replaced |
| 2nd Quarter - Amendment | Dec 6, 2012 | $540,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Patent Settlements
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELLEN JENKINS | — |
| LARA RAMSBURG | — |
Health Issues HCR
S. 3187 - Food and Drug Administration Safety and Innovation Act; S. 1884 - School Access to Emergency Epinephrine Act; Drug shortages; Patent settlements; Serialization; Issues related to HIV/AIDS; Funding for antiretrovirals, PEPFAR, Global Fund, FDA; Issues relating to biogenerics; Issues relating to the generic drug industry; Issues relating to Average Manufacturer Price (AMP)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELLEN JENKINS | — |
| BRUCE LOTT | — |
| LARA RAMSBURG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.